AVAX Technologies Inc. (AVXT) Stock Quote

Detailed Quote for AVAX Technologies Inc. (AVXT)

close 52 Week Information

52 Week High

January 24, 2012

Close: 0.08

52 Week Low

September 15, 2011

Close: 0.02

Today

5d

1m

3m

1y

more

Last Price
0.058

Change $
0.003

Change %
5.45%

Tick
N/A

Bid
N/A

Bid Size
N/A

Ask
N/A

Ask Size
N/A

Open
0.0525

High
0.058

Low
0.0525

Prev Close
0.055

Last Trade
2/10/12

Volume
24.5 k

52 Wk Hi
0.08

52 Wk Low
0.02

Market Cap
8.27 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
142,605,753

EPS (TTM)
N/A

PE Ratio
N/A

close Exchange Information Listed On OTC Pink (OTCPK) Exchange
OTCPK

News and Media for AVAX Technologies Inc. (AVXT)

Sector News | Topic News

News for AVXT

Mon, Sep 27, 2010

2:17 PM

Anavex Life Sciences Corp.: Corporate Update - Newsfile

More News for AVXT >>

Tags for AVAX Technologies Inc.

Research stocks or mutual funds related to AVAX Technologies Inc. by keywords or tags. Find companies that have a similar focus to AVXT. The keywords below have been associated to AVXT by either user submission or electronic means.

tech pharmaceutical pharmaceutical courses clinical trials database clinical research trial pharmaceutical training outsourcing clinical trials mmr vaccine clinical research staffing clinical research training melanoma treatment Biological Products tumor immunology pharmaceutical practice pharmaceutical quality control executive phase iii clinical trials prostate cancer clinical research t cell positive board of directors role vaccine adjuvants follicular dendritic cell pharma fda clinical trial t cell clones t cell receptor medical research biotech corporation t cell immune skin cancer pharmaceutical tech training immunology patient recruitment clinical trials biotechnology research Drugs cancer clinical trial crossroads research clinical pharmaceutical engineering immune system follicular dendritic cells squamus cell clinical drug trials pharmaceutical industry pharmaceutical staffing board of directors responsibility vaccine cell therapies clinical research trials

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.